Cancer Research PRL Inhibitor Induces the Cleavage of p130Cas  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 606-611, January 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bussemakers, M. J. G.
Right arrow Articles by Schalken, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bussemakers, M. J. G.
Right arrow Articles by Schalken, J. A.

Identification of High Mobility Group Protein I(Y) as Potential Progression Marker for Prostate Cancer by Differential Hybridization Analysis1

Marion J. G. Bussemakers, Wim J. M. van de Ven2, Frans M. J. Debruyne and Jack A. Schalken3

Urological Research Laboratory, Departments of Urology [M. J. G. B., F. D., J. A. S.] and Biochemistry [W. J. M. v. d. V.], Radboud University Hospital, P. O. Box 9101, 6500 HB Nijmegen, The Netherlands

One of the major problems in the diagnosis of localized prostatic tumors is to predict the aggressiveness of an individual tumor, which is presumably associated with chance to progression. In an attempt to find molecular markers that are specific for aggressive prostatic cancer cells, we compared steady-state mRNA levels of progressionally related prostatic tumors. The Dunning R-3327-H subline, a relatively benign rat prostatic tumor, was compared to the therefrom derived highly aggressive MatLyLu tumor by differential hybridization analysis. The differential screening revealed 26 complementary DNA clones that detected transcripts overexpressed in MatLyLu. Upon further screening on the entire panel of Dunning R-3327 sublines, it appeared that three clones (pBUS1, pBUS19, and pBUS30), detected transcripts specifically expressed in metastatic rat prostatic tumors. The expression pattern of pBUS19 and pBUS30 suggested a relation between these complementary DNAs. Nucleotide sequence analysis, however, could not yet substantiate this. Computer-assisted comparison of the DNA sequences revealed the presence of rat long terminal repeat-like repetitive elements in pBUS19. The differential expression of repetitive elements in progressionally related tumors is interesting, yet similar findings have not been reported in human malignancies. Nucleotide sequence analysis of pBUS1 indicated that this clone is identical or related to high mobility group protein I(Y), a non-histone nuclear protein. From recent studies it appeared that this protein might be implicated in replication and/or transcription processes and is induced in fast proliferating/undifferentiated cells. The overexpression of high mobility group protein I(Y) correlates rather with metastatic ability than with growth rate; hence it may serve as a valuable marker to identify progressionally advanced prostate cancer cells.

1 These studies were supported by the Dutch Cancer Foundation (NUKC 90-01) and the Royal Dutch Academy of Arts and Sciences.

2 Present address: Center for Human Genetics, University of Leuven, Leuven, Belgium.

3 To whom requests for reprints should be addressed.

Received 8/ 2/90. Accepted 10/26/90.




This article has been cited by other articles:


Home page
Cancer Res.Home page
I. Cleynen, C. Huysmans, T. Sasazuki, S. Shirasawa, W. Van de Ven, and K. Peeters
Transcriptional Control of the Human High Mobility Group A1 Gene: Basal and Oncogenic Ras-Regulated Expression
Cancer Res., May 15, 2007; 67(10): 4620 - 4629.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. D. Edberg, J. N. Adkins, D. L. Springer, and R. Reeves
Dynamic and Differential in Vivo Modifications of the Isoform HMGA1a and HMGA1b Chromatin Proteins
J. Biol. Chem., March 11, 2005; 280(10): 8961 - 8973.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
F. Hommura, M. Katabami, V. D. Leaner, H. Donninger, T. F. Sumter, L. M.S. Resar, and M. J. Birrer
HMG-I/Y Is a c-Jun/Activator Protein-1 Target Gene and Is Necessary for c-Jun-Induced Anchorage-Independent Growth in Rat1a Cells
Mol. Cancer Res., May 1, 2004; 2(5): 305 - 314.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. M. Pierantoni, S. Battista, F. Pentimalli, M. Fedele, R. Visone, A. Federico, M. Santoro, G. Viglietto, and A. Fusco
A truncated HMGA1 gene induces proliferation of the 3T3-L1 pre-adipocytic cells: a model of human lipomas
Carcinogenesis, December 1, 2003; 24(12): 1861 - 1869.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Scala, G. Portella, D. Vitagliano, C. Ledent, G. Chiappetta, V. Giancotti, J. Dumont, and A. Fusco
HMGI-C gene expression is not required for in vivo thyroid cell transformation
Carcinogenesis, February 1, 2001; 22(2): 251 - 256.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. Reeves, D. D. Edberg, and Y. Li
Architectural Transcription Factor HMGI(Y) Promotes Tumor Progression and Mesenchymal Transition of Human Epithelial Cells
Mol. Cell. Biol., January 15, 2001; 21(2): 575 - 594.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
L. J. Wood, M. Mukherjee, C. E. Dolde, Y. Xu, J. F. Maher, T. E. Bunton, J. B. Williams, and L. M. S. Resar
HMG-I/Y, a New c-Myc Target Gene and Potential Oncogene
Mol. Cell. Biol., August 1, 2000; 20(15): 5490 - 5502.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
L. J. Wood, J. F. Maher, T. E. Bunton, and L. M. S. Resar
The Oncogenic Properties of the HMG-I Gene Family
Cancer Res., August 1, 2000; 60(15): 4256 - 4261.
[Abstract] [Full Text]


Home page
FASEB J.Home page
L. C. FOSTER, P. WIESEL, G. S. HUGGINS, R. PAÑARES, M. T. CHIN, A. PELLACANI, and M. A. PERRELLA
Role of activating protein-1 and high mobility group-I(Y) protein in the induction of CD44 gene expression by interleukin-1{beta} in vascular smooth muscle cells
FASEB J, February 1, 2000; 14(2): 368 - 378.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
E. van Garderen, H. J. A. van der Poel, J. F. Swennenhuis, E. H. J. Wissink, G. R. Rutteman, E. Hellmén, J. A. Mol, and J. A. Schalken
Expression and Molecular Characterization of the Growth Hormone Receptor in Canine Mammary Tissue and Mammary Tumors
Endocrinology, December 1, 1999; 140(12): 5907 - 5914.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
M. J. G. Bussemakers, A. van Bokhoven, G. W. Verhaegh, F. P. Smit, H. F. M. Karthaus, J. A. Schalken, F. M. J. Debruyne, N. Ru, and W. B. Isaacs
DD3::A New Prostate-specific Gene, Highly Overexpressed in Prostate Cancer
Cancer Res., December 1, 1999; 59(23): 5975 - 5979.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Nacht, A. T. Ferguson, W. Zhang, J. M. Petroziello, B. P. Cook, Y. H. Gao, S. Maguire, D. Riley, G. Coppola, G. M. Landes, et al.
Combining Serial Analysis of Gene Expression and Array Technologies to Identify Genes Differentially Expressed in Breast Cancer
Cancer Res., November 1, 1999; 59(21): 5464 - 5470.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W.-M. Liu, F. K. Guerra-Vladusic, S. Kurakata, R. Lupu, and T. Kohwi-Shigematsu
HMG-I(Y) Recognizes Base-unpairing Regions of Matrix Attachment Sequences and Its Increased Expression Is Directly Linked to Metastatic Breast Cancer Phenotype
Cancer Res., November 1, 1999; 59(22): 5695 - 5703.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. H. Rondinelli and J. V. Tricoli
CLAR1, a Novel Gene That Exhibits Enhanced Expression in Advanced Human Prostate Cancer
Clin. Cancer Res., June 1, 1999; 5(6): 1595 - 1602.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Giannini, L. Di Marcotullio, E. Ristori, M. Zani, M. Crescenzi, S. Scarpa, G. Piaggio, A. Vacca, F. A. Peverali, F. Diana, et al.
HMGI(Y) and HMGI-C Genes Are Expressed in Neuroblastoma Cell Lines and Tumors and Affect Retinoic Acid Responsiveness
Cancer Res., May 1, 1999; 59(10): 2484 - 2492.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Abe, T. Watanabe, M. Sugiyama, H. Uchimura, G. Chiappetta, A. Fusco, and Y. Atomi
Determination of High Mobility Group I(Y) Expression Level in Colorectal Neoplasias: A Potential Diagnostic Marker
Cancer Res., March 1, 1999; 59(6): 1169 - 1174.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Pellacani, M. T. Chin, P. Wiesel, M. Ibanez, A. Patel, S.-F. Yet, C.-M. Hsieh, J. D. Paulauskis, R. Reeves, M.-E. Lee, et al.
Induction of High Mobility Group-I(Y) Protein by Endotoxin and Interleukin-1beta in Vascular Smooth Muscle Cells. ROLE IN ACTIVATION OF INDUCIBLE NITRIC OXIDE SYNTHASE
J. Biol. Chem., January 15, 1999; 274(3): 1525 - 1532.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S Bonne, J van Hengel, F Nollet, P Kools, and F van Roy
Plakophilin-3, a novel armadillo-like protein present in nuclei and desmosomes of epithelial cells
J. Cell Sci., January 7, 1999; 112(14): 2265 - 2276.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
S. A. Ogram and R. Reeves
Differential Regulation of a Multipromoter Gene
J. Biol. Chem., June 9, 1995; 270(23): 14235 - 14242.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. S. Nissen and R. Reeves
Changes in Superhelicity Are Introduced into Closed Circular DNA by Binding of High Mobility Group Protein I/Y
J. Biol. Chem., March 3, 1995; 270(9): 4355 - 4360.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.